Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
136 participants
INTERVENTIONAL
2015-04-01
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To further evaluate the immediate, long-term and cumulative effects of Tian Jiu Therapy on asthma.
Hypothesis to be tested:
The efficacy of Tian Jiu Therapy on asthma is also long-term and will be accumulated.
Design and Subjects:
Recruiting 167 asthma participants who received Tian Jiu Therapy under the primary study of HKCTR-1128. All subjects should be above age 13 and receive the same Tian Jiu Therapy, 3 times per year from 2013 to 2015. A one-year follow-up after the last Tian Jiu treatment will be conducted.
Study instruments:
Modern USB PC-based Spirometer and Fingertip Pulse Oximeter.
Interventions:
Plastering some stimulating Chinese herbal cubes on certain acupoints in the three hottest days of each year, for three consecutive years.
Main outcome measures:
Pulmonary Function Test, Blood Oxygen Test, Quality of Life and Standardized Questionnaire on asthma attack and symptoms will be administered before treatment, after treatment of each year and one-year follow-up after the last treatment.
Data analysis:
All the parameters will be analyzed, the physical improvement (Cured, Remarkably effective, Effective and Ineffective) will be recorded, and the differences in different treatment courses will be investigated and compared with previous data obtained in the primary study of HKCTR-1128 by using standard statistical analysis.
Expected results:
The effect of Tian Jiu Therapy on Asthma is not only immediate but also long-term and will be gradually accumulated.
The Tian Jiu Therapy will acquire better efficacy on asthma if this treatment was conducted more years continuously.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma
NCT00636103
Chinese Herbal Medicine Formula Combined With Inhaled Corticosteroids for the Treatment of Mild to Persistent Asthma in Children
NCT05066841
Traditional Chinese Medicine in Management of Childhood Asthma
NCT03645889
Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China
NCT02965807
Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in China
NCT03156998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tian Jiu Therapy
Tian Jiu Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tian Jiu Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Diagnostic Criteria of Asthma according to U.S.DHHS(2007):
1. Episodic symptoms of airflow obstruction
2. Difficulty breathing
3. Chest tightness
4. Cough (worse at night)
5. Symptoms occurring or worsening at night, awakening the patient
6. Symptoms occurring or worsening with exercise, viral infections, changes in weather, strong emotions, or mens; or in the presence of animals, dust mites, mold, smoke, pollen, or chemicals
7. Wheezing
8. Airflow obstruction at least partially reversible Medically stable and acute medical care does not require. E.g. intensive monitoring, invasive ventilation, haemoid-dialysis, cardiac support.
Exclusion Criteria
2. Infants and child under thirteen years old 3.Pregnant women
4\. Patients with
1. Fever and pharyngitis
2. Tuberculosis
3. Severe cardiac and pulmonary diseases
4. Diabetes Mellitus
5. Hypersensitive skin condition
6. Allergy to topical medication
7. Keloid
8. Bleeding disorders
9. Severe heart diseases and with pacemaker.
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HHSRF 12133081
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.